A novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report

Uncommon epidermal growth factor receptor (EGFR) mutations are increasingly being identified in non-small cell lung cancer. Insertion and deletion mutations have been detected in exons 18, 19, and 20, but not in exon 21. In patients with uncommon mutations, the second-generation EGFR tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Tao, Xiong, Qiang, Hong, Chen, Wang, Qian, Wang, Wenxian, Xu, Chunwei, Cai, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410616/
https://www.ncbi.nlm.nih.gov/pubmed/36042660
http://dx.doi.org/10.1097/MD.0000000000030269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410616/
https://www.ncbi.nlm.nih.gov/pubmed/36042660
http://dx.doi.org/10.1097/MD.0000000000030269

Ejemplares similares